Ledger.Open graph →
SEC Form D · filed December 1, 2016

Neurotrope, Inc

Offering
$24.5M
Sold
$24.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Robert Weinstein · New York, NYExecDan Alkon · New York, NYExecBruce Bernstein · New York, NYDirectorJoshua Silverman · Luxembourg, LuxembourgDirectorRobert Weinstein · Irvington, NYExecJames Gottlieb · New York, NYDirectorShana Phares · New York, NYDirectorKenneth Gorelick · New York, NYDirectorWilliam Singer · CHICAGO, ILDirectorSusanne Wilke · New York, NYExec · DirectorJoshua Silverman · New York, NYDirectorRobert Weinstein · New York, NYExecJames Gottlieb · New York, NYDirectorShana Phares · New York, NYDirectorKenneth Gorelick · New York, NYDirectorDan Alkon · New York, NYExecWilliam Singer · New York, NYDirectorBruce Bernstein · New York, NYDirectorSusanne Wilke · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗